Mickaël Durand-Dubief
Research Subjects
Mickaël Durand-Dubief has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
- Karl Ekwall
Department of Medicine, Karolinska Institutet
19 shared publications - Edouard Alphandéry
Nanobacterie SARL, Paris, France
8 shared publications Imène Chebbi
7 shared publications- Philippe Bastin
Institut Pasteur
5 shared publications François Guyot
4 shared publicationsRobin Dessalles
Nutrition & Health, Robin Dessalles EI
4 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1777596
Fermentation in breadmaking: enhancing digestibility and nutritional value for gastrointestinal health
Fermentation is a traditional food process that has been used for ages, notably contributing to the production of bread, one of the main staple foods. The aim of this review is to explore how fermentation may be leveraged to enhance the digestibility and nutritional value of bread, addressing potential gastrointestinal disorders related to its consumption. Emerging gastrointestinal disorders such as non-celiac gluten or wheat sensitivity and irritable bowel syndrome (IBS) are discussed, highlighting the complex and often poorly understood, nature of these conditions involving both physiological and psychological aspects. Yeasts and lactic acid bacteria used in the bread making process can positively influence bread characteristics through the enhancement of mineral bioaccessibility or the reduction of triggering components like gluten and FODMAPs, especially when selecting microorganisms with targeted properties. However, the characterization and selection of these microorganisms require further standardization, and the clinical implications need to be firmly established as the strength of the evidence remains insufficient. The review also discusses the potential for fermentation to generate beneficial metabolites, such as exopolysaccharides (EPS) and short-chain fatty acids (SCFA). While these compounds show promise, their actual content, stability, and bioavailability in baked bread require further investigation. Overall, fermentation appears as a versatile transformative tool for the creation of digestible and nutritionally enhanced bread. Yet well-designed human studies are needed to substantiate the clinical benefits and better define the conditions where modification through fermentation may provide gastrointestinal health advantages.
- 21 May 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1777596
Open AccessFermentation in breadmaking: enhancing digestibility and nutritional value for gastrointestinal health
Fermentation is a traditional food process that has been used for ages, notably contributing to the production of bread, one of the main staple foods. The aim of this review is to explore how fermentation may be leveraged to enhance the digestibility and nutritional value of bread, addressing potential gastrointestinal disorders related to its consumption. Emerging gastrointestinal disorders such as non-celiac gluten or wheat sensitivity and irritable bowel syndrome (IBS) are discussed, highlighting the complex and often poorly understood, nature of these conditions involving both physiological and psychological aspects. Yeasts and lactic acid bacteria used in the bread making process can positively influence bread characteristics through the enhancement of mineral bioaccessibility or the reduction of triggering components like gluten and FODMAPs, especially when selecting microorganisms with targeted properties. However, the characterization and selection of these microorganisms require further standardization, and the clinical implications need to be firmly established as the strength of the evidence remains insufficient. The review also discusses the potential for fermentation to generate beneficial metabolites, such as exopolysaccharides (EPS) and short-chain fatty acids (SCFA). While these compounds show promise, their actual content, stability, and bioavailability in baked bread require further investigation. Overall, fermentation appears as a versatile transformative tool for the creation of digestible and nutritionally enhanced bread. Yet well-designed human studies are needed to substantiate the clinical benefits and better define the conditions where modification through fermentation may provide gastrointestinal health advantages.
- Open Access
- 22 October 2025
- Published by Elsevier in Current Developments in Nutrition
- Vol. 9 (11)
Vitamin D Nutritional Status in the Middle East and North Africa Region: A Systematic Review and Meta-analysis
- 22 October 2025
- Published by Elsevier in Current Developments in Nutrition
- Vol. 9 (11)
Open AccessVitamin D Nutritional Status in the Middle East and North Africa Region: A Systematic Review and Meta-analysis
- Top Cited PapersOpen Access
- 20 March 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1369950
Harnessing the power of resistant starch: a narrative review of its health impact and processing challenges
Starch is a primary energy storage for plants, making it an essential component of many plant-based foods consumed today. Resistant starch (RS) refers to those starch fractions that escape digestion in the small intestine and reach the colon where they are fermented by the microflora. RS has been repeatedly reported as having benefits on health, but ensuring that its content remains in food processing may be challenging. The present work focuses on the impact RS on health and explores the different processes that may influence its presence in foods, thus potentially interfering with these effects. Clinical evidence published from 2010 to 2023 and studying the effect of RS on health parameters in adult populations, were identified, using PUBMED/Medline and Cochrane databases. The search focused as well on observational studies related to the effect of food processes on RS content. While processes such as milling, fermentation, cooking and heating seem to have a deleterious influence on RS content, other processes, such as cooling, cooking time, storage time, or water content, may positively impact its presence. Regarding the influence on health parameters, there is a body of evidence suggesting an overall significant beneficial effect of RS, especially type 1 and 2, on several health parameters such as glycemic response, insulin resistance index, bowel function or inflammatory markers. Effects are more substantiated in individuals suffering from metabolic diseases. The effects of RS may however be exerted differently depending on the type. A better understanding of the influence of food processes on RS can guide the development of dietary intake recommendations and contribute to the development of food products rich in RS.
- 20 March 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1369950
Top Cited PapersOpen AccessHarnessing the power of resistant starch: a narrative review of its health impact and processing challenges
Starch is a primary energy storage for plants, making it an essential component of many plant-based foods consumed today. Resistant starch (RS) refers to those starch fractions that escape digestion in the small intestine and reach the colon where they are fermented by the microflora. RS has been repeatedly reported as having benefits on health, but ensuring that its content remains in food processing may be challenging. The present work focuses on the impact RS on health and explores the different processes that may influence its presence in foods, thus potentially interfering with these effects. Clinical evidence published from 2010 to 2023 and studying the effect of RS on health parameters in adult populations, were identified, using PUBMED/Medline and Cochrane databases. The search focused as well on observational studies related to the effect of food processes on RS content. While processes such as milling, fermentation, cooking and heating seem to have a deleterious influence on RS content, other processes, such as cooling, cooking time, storage time, or water content, may positively impact its presence. Regarding the influence on health parameters, there is a body of evidence suggesting an overall significant beneficial effect of RS, especially type 1 and 2, on several health parameters such as glycemic response, insulin resistance index, bowel function or inflammatory markers. Effects are more substantiated in individuals suffering from metabolic diseases. The effects of RS may however be exerted differently depending on the type. A better understanding of the influence of food processes on RS can guide the development of dietary intake recommendations and contribute to the development of food products rich in RS.
- Open Access
- 13 May 2023
- Published by MDPI AG in Encyclopedia
- Vol. 3 (2) , 602-613
Saccharomyces cerevisiae: Multifaceted Applications in One Health and the Achievement of Sustainable Development Goals
Saccharomyces cerevisiae (SC), a yeast with an extensive history in food and beverage fermentations, is increasingly acknowledged for its multifaceted application in promoting and benefiting all aspects of a ‘One Health’ approach, including the prevention and control of zoonoses. For instance, SC contributes to environmentally sustainable agricultural practices through the reduced use of toxic agents, thus minimizing air and soil pollution while enhancing crop quality. Additionally, this versatile yeast can improve the health of domestic and farm animals, leading to more efficient and sustainable food production, while fostering synergistic impacts across environmental, animal, and human health spheres. Moreover, SC directly applies benefits to human health by promoting improved nutrition, improving gut health through probiotics, as an alternative to antibiotics, and treating gastric disorders. By aligning with several Sustainable Development Goals (SDGs), SC is vital in advancing global health and well-being, environmental sustainability, and responsible consumption and production. This entry illustrates the numerous benefits of SC and highlights its significant impact on a global ‘One Health’ scale, promoting the achievement of SDGs through its unique characteristics and deeper understanding of its contribution to the One Health concept.
- 13 May 2023
- Published by MDPI AG in Encyclopedia
- Vol. 3 (2) , 602-613
Open AccessSaccharomyces cerevisiae: Multifaceted Applications in One Health and the Achievement of Sustainable Development Goals
Saccharomyces cerevisiae (SC), a yeast with an extensive history in food and beverage fermentations, is increasingly acknowledged for its multifaceted application in promoting and benefiting all aspects of a ‘One Health’ approach, including the prevention and control of zoonoses. For instance, SC contributes to environmentally sustainable agricultural practices through the reduced use of toxic agents, thus minimizing air and soil pollution while enhancing crop quality. Additionally, this versatile yeast can improve the health of domestic and farm animals, leading to more efficient and sustainable food production, while fostering synergistic impacts across environmental, animal, and human health spheres. Moreover, SC directly applies benefits to human health by promoting improved nutrition, improving gut health through probiotics, as an alternative to antibiotics, and treating gastric disorders. By aligning with several Sustainable Development Goals (SDGs), SC is vital in advancing global health and well-being, environmental sustainability, and responsible consumption and production. This entry illustrates the numerous benefits of SC and highlights its significant impact on a global ‘One Health’ scale, promoting the achievement of SDGs through its unique characteristics and deeper understanding of its contribution to the One Health concept.
- Open Access
- 15 December 2022
- Published by Elsevier in Advances in Nutrition
- Vol. 14 (1) , 22-29
Nutritional benefits of sourdoughs: A systematic review
- 15 December 2022
- Published by Elsevier in Advances in Nutrition
- Vol. 14 (1) , 22-29
Open AccessNutritional benefits of sourdoughs: A systematic review
- Open Access
- 6 August 2022
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 200, 106556
Viability of Saccharomyces cerevisiae during baking of bread dough by flow cytometry
- 6 August 2022
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 200, 106556
Open AccessViability of Saccharomyces cerevisiae during baking of bread dough by flow cytometry
- Open Access
- 27 November 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (23) , 9022
High-Throughput Flow Cytometry Combined with Genetic Analysis Brings New Insights into the Understanding of Chromatin Regulation of Cellular Quiescence
Cellular quiescence is a reversible differentiation state when cells are changing the gene expression program to reduce metabolic functions and adapt to a new cellular environment. When fission yeast cells are deprived of nitrogen in the absence of any mating partner, cells can reversibly arrest in a differentiated G0-like cellular state, called quiescence. This change is accompanied by a marked alteration of nuclear organization and a global reduction of transcription. Using high-throughput flow cytometry combined with genetic analysis, we describe the results of a comprehensive screen for genes encoding chromatin components and regulators that are required for the entry and the maintenance of cellular quiescence. We show that the histone acetylase and deacetylase complexes, SAGA and Rpd3, have key roles both for G0 entry and survival during quiescence. We reveal a novel function for the Ino80 nucleosome remodeling complex in cellular quiescence. Finally, we demonstrate that components of the MRN complex, Rad3, the nonhomologous end-joining, and nucleotide excision DNA repair pathways are essential for viability in G0.
- 27 November 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (23) , 9022
Open AccessHigh-Throughput Flow Cytometry Combined with Genetic Analysis Brings New Insights into the Understanding of Chromatin Regulation of Cellular Quiescence
Cellular quiescence is a reversible differentiation state when cells are changing the gene expression program to reduce metabolic functions and adapt to a new cellular environment. When fission yeast cells are deprived of nitrogen in the absence of any mating partner, cells can reversibly arrest in a differentiated G0-like cellular state, called quiescence. This change is accompanied by a marked alteration of nuclear organization and a global reduction of transcription. Using high-throughput flow cytometry combined with genetic analysis, we describe the results of a comprehensive screen for genes encoding chromatin components and regulators that are required for the entry and the maintenance of cellular quiescence. We show that the histone acetylase and deacetylase complexes, SAGA and Rpd3, have key roles both for G0 entry and survival during quiescence. We reveal a novel function for the Ino80 nucleosome remodeling complex in cellular quiescence. Finally, we demonstrate that components of the MRN complex, Rad3, the nonhomologous end-joining, and nucleotide excision DNA repair pathways are essential for viability in G0.
- Open Access
- 8 April 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-13
Abo1 is required for the H3K9me2 to H3K9me3 transition in heterochromatin
Heterochromatin regulation is critical for genomic stability. Different H3K9 methylation states have been discovered, with distinct roles in heterochromatin formation and silencing. However, how the transition from H3K9me2 to H3K9me3 is controlled is still unclear. Here, we investigate the role of the conserved bromodomain AAA-ATPase, Abo1, involved in maintaining global nucleosome organisation in fission yeast. We identified several key factors involved in heterochromatin silencing that interact genetically with Abo1: histone deacetylase Clr3, H3K9 methyltransferase Clr4, and HP1 homolog Swi6. Cells lacking Abo1 cultivated at 30 °C exhibit an imbalance of H3K9me2 and H3K9me3 in heterochromatin. In abo1∆ cells, the centromeric constitutive heterochromatin has increased H3K9me2 but decreased H3K9me3 levels compared to wild-type. In contrast, facultative heterochromatin regions exhibit reduced H3K9me2 and H3K9me3 levels in abo1∆. Genome-wide analysis showed that abo1∆ cells have silencing defects in both the centromeres and subtelomeres, but not in a subset of heterochromatin islands in our condition. Thus, our work uncovers a role of Abo1 in stabilising directly or indirectly Clr4 recruitment to allow the H3K9me2 to H3K9me3 transition in heterochromatin.
- 8 April 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-13
Open AccessAbo1 is required for the H3K9me2 to H3K9me3 transition in heterochromatin
Heterochromatin regulation is critical for genomic stability. Different H3K9 methylation states have been discovered, with distinct roles in heterochromatin formation and silencing. However, how the transition from H3K9me2 to H3K9me3 is controlled is still unclear. Here, we investigate the role of the conserved bromodomain AAA-ATPase, Abo1, involved in maintaining global nucleosome organisation in fission yeast. We identified several key factors involved in heterochromatin silencing that interact genetically with Abo1: histone deacetylase Clr3, H3K9 methyltransferase Clr4, and HP1 homolog Swi6. Cells lacking Abo1 cultivated at 30 °C exhibit an imbalance of H3K9me2 and H3K9me3 in heterochromatin. In abo1∆ cells, the centromeric constitutive heterochromatin has increased H3K9me2 but decreased H3K9me3 levels compared to wild-type. In contrast, facultative heterochromatin regions exhibit reduced H3K9me2 and H3K9me3 levels in abo1∆. Genome-wide analysis showed that abo1∆ cells have silencing defects in both the centromeres and subtelomeres, but not in a subset of heterochromatin islands in our condition. Thus, our work uncovers a role of Abo1 in stabilising directly or indirectly Clr4 recruitment to allow the H3K9me2 to H3K9me3 transition in heterochromatin.
- Open Access
- 10 January 2020
- Published by Taylor & Francis in Epigenetics
- Vol. 15 (6-7) , 702-714
A regulatory role for CHD2 in myelopoiesis
The transcriptional program that dictates haematopoietic cell fate and differentiation requires an epigenetic regulatory and memory function, provided by a network of epigenetic factors that regulate DNA methylation, post-translational histone modifications and chromatin structure. Disturbed epigenetic regulation causes perturbations in the blood cell differentiation program that results in various types of haematopoietic disorders. Thus, accurate epigenetic regulation is essential for functional haematopoiesis. In this study, we used a CRISPR-Cas9 screening approach to identify new epigenetic regulators in myeloid differentiation. We designed a Chromatin-UMI CRISPR guide library targeting 1092 epigenetic regulators. Phorbol 12-myristate 13-acetate (PMA) treatment of the chronic myeloid leukaemia cell line K-562 was used as a megakaryocytic myeloid differentiation model. Both previously described developmental epigenetic regulators and novel factors were identified in our screen. In this study, we validated and characterized a role for the chromatin remodeller CHD2 in myeloid proliferation and megakaryocytic differentiation.
- 10 January 2020
- Published by Taylor & Francis in Epigenetics
- Vol. 15 (6-7) , 702-714
Open AccessA regulatory role for CHD2 in myelopoiesis
The transcriptional program that dictates haematopoietic cell fate and differentiation requires an epigenetic regulatory and memory function, provided by a network of epigenetic factors that regulate DNA methylation, post-translational histone modifications and chromatin structure. Disturbed epigenetic regulation causes perturbations in the blood cell differentiation program that results in various types of haematopoietic disorders. Thus, accurate epigenetic regulation is essential for functional haematopoiesis. In this study, we used a CRISPR-Cas9 screening approach to identify new epigenetic regulators in myeloid differentiation. We designed a Chromatin-UMI CRISPR guide library targeting 1092 epigenetic regulators. Phorbol 12-myristate 13-acetate (PMA) treatment of the chronic myeloid leukaemia cell line K-562 was used as a megakaryocytic myeloid differentiation model. Both previously described developmental epigenetic regulators and novel factors were identified in our screen. In this study, we validated and characterized a role for the chromatin remodeller CHD2 in myeloid proliferation and megakaryocytic differentiation.